Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00831480
Title Everolimus(RAD001) For Advanced Renal Cell Carcinoma(RCC)Before Kidney Removal
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilad Amiel
Indications

chromophobe renal cell carcinoma

papillary renal cell carcinoma

clear cell renal cell carcinoma

Therapies

Everolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.